©2022 Stanford Medicine
Lymphedema Study for Arm or Leg Lymphedema
Trial ID: NCT02257970
This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
Placebo-controlled, Case-controlled, Open Label Therapeutic Trial for Unilateral or Bilateral Lymphedema of Arm or Leg.
- a history of lymphedema of one or more limbs (unilateral or bilateral), with a
duration of > 6 months.
- Patients with active cancer, infection or bleeding tendency will be excluded.
- We will also exclude patients with medical contraindications to NSAIDs, including
history of allergies, know gastrointestinal intolerance, or other serious systemic
illness (e.g., renal failure, hepatic dysfunction, congestive heart failure,
neurological or psychological impairment) that would impair the patients' ability to
- Minors (<18 years of age) *>90 years of age
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Leslie Roche, RN